2020
Cannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity
Gibson CL, Bassir Nia A, Spriggs SA, DeFrancisco D, Swift A, Perkel C, Zhong X, Mazumdar M, Fernandez N, Patel M, Kim-Schulze S, Hurd YL. Cannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity. Psychiatry Research 2020, 293: 113380. PMID: 32818918, PMCID: PMC8292796, DOI: 10.1016/j.psychres.2020.113380.Peer-Reviewed Original ResearchConceptsInterleukin-6Psychosis severityCannabinoid useCannabis useIL-6 levelsCommon underlying pathologyPANSS total scoreChronic psychotic disordersRisk of psychosisPsychiatric emergency roomNegative Syndrome ScalePsychotic symptom severityInflammatory alterationsInflammatory markersInflammatory disturbancesAcute psychosisInflammatory abnormalitiesNata medicationUnderlying pathologyEmergency roomInflammatory levelsPANSS scoresPsychiatric unitUnadjusted modelsPsychotic disorders
2018
Cannabis Use: Neurobiological, Behavioral, and Sex/Gender Considerations
Bassir Nia A, Mann C, Kaur H, Ranganathan M. Cannabis Use: Neurobiological, Behavioral, and Sex/Gender Considerations. Current Behavioral Neuroscience Reports 2018, 5: 271-280. PMID: 31548918, PMCID: PMC6756752, DOI: 10.1007/s40473-018-0167-4.Peer-Reviewed Original ResearchEffects of cannabinoidsGender-related differencesMood/psychotic disordersPurpose of ReviewToSex/gender considerationsRate of useRisk of addictionAdverse outcomesClinical dataPsychotic disordersCognitive deficitsConstituent cannabinoidsGreater riskSubstance useCannabinoidsWomenHuman dataCurrent literatureFuture studiesSexRisk